ALX Oncology adopts 2025 Inducement Plan, reserves 1.5M shares for new-hire equity awards

ALX ONCOLOGY HOLDINGS INC

Board approved Inducement Plan on Jan 16, 2025; effective immediately.
1,500,000 shares of common stock reserved for issuance under the plan.
Awards are limited to new employees as a material inducement to join the company, per Nasdaq Listing Rule 5635(c)(4).
Plan terms are substantially similar to ALX's existing 2020 Equity Incentive Plan.
No shareholder approval was required for adoption.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.